Hereditary Transthyretin Amyloidosis and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hereditary Transthyretin Amyloidosis (HATTR) Overall Market Size
2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size: 2022 VS 2029
2.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hereditary Transthyretin Amyloidosis (HATTR) Players in Global Market
3.2 Top Global Hereditary Transthyretin Amyloidosis (HATTR) Companies Ranked by Revenue
3.3 Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Companies
3.4 Top 3 and Top 5 Hereditary Transthyretin Amyloidosis (HATTR) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hereditary Transthyretin Amyloidosis (HATTR) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hereditary Transthyretin Amyloidosis (HATTR) Players in Global Market
3.6.1 List of Global Tier 1 Hereditary Transthyretin Amyloidosis (HATTR) Companies
3.6.2 List of Global Tier 2 and Tier 3 Hereditary Transthyretin Amyloidosis (HATTR) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Subcutaneous Injection
4.1.4 Others
4.2 By Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue & Forecasts
4.2.1 By Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2018-2023
4.2.2 By Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2024-2029
4.2.3 By Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue & Forecasts
5.2.1 By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2018-2023
5.2.2 By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2024-2029
5.2.3 By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2022 & 2029
6.2 By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue & Forecasts
6.2.1 By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2018-2023
6.2.2 By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2024-2029
6.2.3 By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2018-2029
6.3.2 US Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.3.3 Canada Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.3.4 Mexico Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2018-2029
6.4.2 Germany Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.4.3 France Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.4.4 U.K. Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.4.5 Italy Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.4.6 Russia Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.4.7 Nordic Countries Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.4.8 Benelux Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2018-2029
6.5.2 China Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.5.3 Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.5.4 South Korea Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.5.5 Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.5.6 India Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2018-2029
6.6.2 Brazil Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.6.3 Argentina Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2018-2029
6.7.2 Turkey Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.7.3 Israel Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.7.4 Saudi Arabia Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
6.7.5 UAE Hereditary Transthyretin Amyloidosis (HATTR) Market Size, 2018-2029
7 Hereditary Transthyretin Amyloidosis (HATTR) Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Major Product Offerings
7.1.4 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Alnylam Pharmaceuticals
7.2.1 Alnylam Pharmaceuticals Company Summary
7.2.2 Alnylam Pharmaceuticals Business Overview
7.2.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Major Product Offerings
7.2.4 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global Market (2018-2023)
7.2.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.3 Akcea Therapeutics
7.3.1 Akcea Therapeutics Company Summary
7.3.2 Akcea Therapeutics Business Overview
7.3.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Major Product Offerings
7.3.4 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global Market (2018-2023)
7.3.5 Akcea Therapeutics Key News & Latest Developments
7.4 Prothena
7.4.1 Prothena Company Summary
7.4.2 Prothena Business Overview
7.4.3 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Major Product Offerings
7.4.4 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global Market (2018-2023)
7.4.5 Prothena Key News & Latest Developments
7.5 Lonis Pharmaceuticals
7.5.1 Lonis Pharmaceuticals Company Summary
7.5.2 Lonis Pharmaceuticals Business Overview
7.5.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Major Product Offerings
7.5.4 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global Market (2018-2023)
7.5.5 Lonis Pharmaceuticals Key News & Latest Developments
7.6 Eidos Therapeutics
7.6.1 Eidos Therapeutics Company Summary
7.6.2 Eidos Therapeutics Business Overview
7.6.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Major Product Offerings
7.6.4 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global Market (2018-2023)
7.6.5 Eidos Therapeutics Key News & Latest Developments
7.7 Corino Therapeutics Inc
7.7.1 Corino Therapeutics Inc Company Summary
7.7.2 Corino Therapeutics Inc Business Overview
7.7.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Major Product Offerings
7.7.4 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global Market (2018-2023)
7.7.5 Corino Therapeutics Inc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Hereditary Transthyretin Amyloidosis (HATTR) Market Opportunities & Trends in Global Market
Table 2. Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers in Global Market
Table 3. Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints in Global Market
Table 4. Key Players of Hereditary Transthyretin Amyloidosis (HATTR) in Global Market
Table 5. Top Hereditary Transthyretin Amyloidosis (HATTR) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hereditary Transthyretin Amyloidosis (HATTR) Product Type
Table 9. List of Global Tier 1 Hereditary Transthyretin Amyloidosis (HATTR) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hereditary Transthyretin Amyloidosis (HATTR) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hereditary Transthyretin Amyloidosis (HATTR) Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 32. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Alnylam Pharmaceuticals Company Summary
Table 35. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 36. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn) & (2018-2023)
Table 37. Alnylam Pharmaceuticals Key News & Latest Developments
Table 38. Akcea Therapeutics Company Summary
Table 39. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 40. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn) & (2018-2023)
Table 41. Akcea Therapeutics Key News & Latest Developments
Table 42. Prothena Company Summary
Table 43. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 44. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn) & (2018-2023)
Table 45. Prothena Key News & Latest Developments
Table 46. Lonis Pharmaceuticals Company Summary
Table 47. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 48. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn) & (2018-2023)
Table 49. Lonis Pharmaceuticals Key News & Latest Developments
Table 50. Eidos Therapeutics Company Summary
Table 51. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 52. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn) & (2018-2023)
Table 53. Eidos Therapeutics Key News & Latest Developments
Table 54. Corino Therapeutics Inc Company Summary
Table 55. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product Offerings
Table 56. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue (US$, Mn) & (2018-2023)
Table 57. Corino Therapeutics Inc Key News & Latest Developments
List of Figures
Figure 1. Hereditary Transthyretin Amyloidosis (HATTR) Segment by Type in 2022
Figure 2. Hereditary Transthyretin Amyloidosis (HATTR) Segment by Application in 2022
Figure 3. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hereditary Transthyretin Amyloidosis (HATTR) Revenue in 2022
Figure 8. By Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2018-2029
Figure 9. By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2018-2029
Figure 10. By Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2018-2029
Figure 12. By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2018-2029
Figure 14. By Region - Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2018-2029
Figure 15. By Country - North America Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2018-2029
Figure 16. US Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2018-2029
Figure 20. Germany Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 21. France Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2018-2029
Figure 28. China Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 32. India Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2018-2029
Figure 34. Brazil Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share, 2018-2029
Figure 37. Turkey Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Hereditary Transthyretin Amyloidosis (HATTR) Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
